McKesson (MCK) Tops Q4 EPS by 1c; beats on guidance
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/17/2026
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- Oil rises after US threatens indefinite blockade of Iran; set for weekly gains
- Are KOSPI and SOX in a bubble? Citi answers
- Could Intel return to the red-hot memory market after $20B raise and recent hire?
- S&P 500 ends lower as investors weigh data, Middle East tensions
- SanDisk upgraded at JPMorgan after investor day; shares climb
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- BOJ eyeing September rate hike, faster pace of tightening, sources say
- Micron: New Street upgrades to buy, says memory is no longer a cyclical story
McKesson shares surge as guidance, long-term targets impress
May 9, 2023 11:52 AM EDT(Updated - May 9, 2023 11:57 AM EDT)
Shares of McKesson, a health services company and pharmaceutical distributor, climbed Tuesday, surging by the most in over three years after it reported earnings and guidance that topped consensus.
Revenue for its fiscal fourth quarter climbed 4% to $68.9 billion and adjusted EPS was up 23% to $7.19. Both beat consensus estimates. It also issued 2024 guidance that beat Wall Street... More
